Todays topic will be on updates on the management of chronic kidney disease
Our guest speaker today is Dr Rakesh Gulati
Dr. Gulati is a Clinical Professor of Medicine and the James F. Burke, Jr., MD Nephrology Fellowship Program Director at Thomas Jefferson University Hospital Philadelphia. In this capacity since 2006, he has mentored scores of renal fellows, including career counseling for additional specialization in transplant and critical care. During this time, he has been a recipient of numerous teaching awards, including the Fellowship Director Award, Dean’s Award for Excellence in Teaching, Top 25 Educators in Medicine, and recently, the Excellence in Care Award by the National Kidney Foundation. He has also been named the Top Doctor in Nephrology by the Philadelphia Magazine for each of the last six years.
Dr. Gulati is considered as a master clinician, a scholar of the literature, an invited speaker of national stature, and world class educator of distinction.
We are also joined by nephrologists from Ethiopia; Dr.Bezaye and Dr.Seife
Timestamps:
00:00:00 Introduction to the Webinar
00:03:44 Introduction to CKD: update
00:04:46 Definition of Chronic Kidney Disease
00:06:51 KDOQI 2022 Definition of CKD
00:12:17 GFR Formulas
00:15:38 Risk Factors of CKD
00:17:18 Relative risks of complications of CKD
00:18:46 Background of CKD
00:20:47 Diabetic Kidney disease vs Diabetic Nephropathy (Diabetes and CKD)
00:25:25 How does Kidney disease cause cardiac disease? (Cardiac renal link)
00:29:09 Risk of progression by GFR and Albuminuria
00:32:55 How do SGLT2 inhibitors work?
00:44:46 Reducing CKD Progression
00:51:49 When to refer to a specialist and Late referrals
00:54:58 Take home points on CKD management
00:55:59 Conclusion of CKD management
00:57:10 Break [details of webinar and introduction of the rest of the panel]
01:01:08 Q & A session
01:41:07 Conditions of Management of CKD using SGLT2 inhibitors in Ethiopia
01:47:29 Final words
Our guest speaker today is Dr Rakesh Gulati
Dr. Gulati is a Clinical Professor of Medicine and the James F. Burke, Jr., MD Nephrology Fellowship Program Director at Thomas Jefferson University Hospital Philadelphia. In this capacity since 2006, he has mentored scores of renal fellows, including career counseling for additional specialization in transplant and critical care. During this time, he has been a recipient of numerous teaching awards, including the Fellowship Director Award, Dean’s Award for Excellence in Teaching, Top 25 Educators in Medicine, and recently, the Excellence in Care Award by the National Kidney Foundation. He has also been named the Top Doctor in Nephrology by the Philadelphia Magazine for each of the last six years.
Dr. Gulati is considered as a master clinician, a scholar of the literature, an invited speaker of national stature, and world class educator of distinction.
We are also joined by nephrologists from Ethiopia; Dr.Bezaye and Dr.Seife
Timestamps:
00:00:00 Introduction to the Webinar
00:03:44 Introduction to CKD: update
00:04:46 Definition of Chronic Kidney Disease
00:06:51 KDOQI 2022 Definition of CKD
00:12:17 GFR Formulas
00:15:38 Risk Factors of CKD
00:17:18 Relative risks of complications of CKD
00:18:46 Background of CKD
00:20:47 Diabetic Kidney disease vs Diabetic Nephropathy (Diabetes and CKD)
00:25:25 How does Kidney disease cause cardiac disease? (Cardiac renal link)
00:29:09 Risk of progression by GFR and Albuminuria
00:32:55 How do SGLT2 inhibitors work?
00:44:46 Reducing CKD Progression
00:51:49 When to refer to a specialist and Late referrals
00:54:58 Take home points on CKD management
00:55:59 Conclusion of CKD management
00:57:10 Break [details of webinar and introduction of the rest of the panel]
01:01:08 Q & A session
01:41:07 Conditions of Management of CKD using SGLT2 inhibitors in Ethiopia
01:47:29 Final words
- Category
- Management

Be the first to comment